| Analysis | Metabolite Name | Measured Value | Units | Sample source | Age | Genotype | Treatment |
|---|---|---|---|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.25130344 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.25874126 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.27872128 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.28258603 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.28871129 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.54375615 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.6027532 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.63636364 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.64646465 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.68686869 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.73058014 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.82662539 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.86652763 | lipid content in the sample (nmol/g) | Heart | NA | MIF | Sham |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.91950464 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 1.99174407 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.09163347 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.1812749 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.22111554 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.23895582 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.41446725 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.45490982 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.48995984 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.58064516 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.60997067 | lipid content in the sample (nmol/g) | Heart | NA | MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.60997067 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.64339152 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.66334165 | lipid content in the sample (nmol/g) | Heart | young | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.66533066 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.6753507 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.68072289 | lipid content in the sample (nmol/g) | Heart | Aged | WT | Sham+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.68817204 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.69175109 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.83646889 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.85276074 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.85988484 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.86412512 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.88867562 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.92732856 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 2.93756397 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 3.06142035 | lipid content in the sample (nmol/g) | Heart | young | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 3.09815951 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 3.11156602 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 3.11860941 | lipid content in the sample (nmol/g) | Heart | Aged | WT | I/R |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 8.65889213 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 8.91156463 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R+MIF20 |
| Reversed phase UNSPECIFIED ION MODE | PE(16:1_20:4) | 9.29057337 | lipid content in the sample (nmol/g) | Heart | NA | KO-MIF | I/R+MIF20 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|